Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia

Vipul Shukla*, Ashima Shukla, Shantaram S. Joshi, Runqing Lu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Molecular pathogenesis of Chronic Lymphocytic Leukemia (CLL) is not fully elucidated. Genome wide association studies have linked Interferon Regulatory Factor 4 (IRF4) to the development of CLL. We recently established a causal relationship between low levels of IRF4 and development of CLL. However, the molecular mechanism through which IRF4 suppresses CLL development remains unclear. Deregulation of Notch signaling pathway has been identified as one of the most recurrent molecular anomalies in the pathogenesis of CLL. Yet, the role of Notch signaling as well as its regulation during CLL development remains poorly understood. Previously, we demonstrated that IRF4 deficient mice expressing immunoglobulin heavy chain Vh11 (IRF4-/-Vh11) developed spontaneous CLL with complete penetrance. In this study, we show that elevated Notch2 expression and the resulting hyperactivation of Notch signaling are common features of IRF4-/-Vh11 CLL cells. Our studies further reveal that Notch signaling is indispensable for CLL development in the IRF4-/-Vh11 mice. Moreover, we identify E3 ubiquitin ligase Nedd4, which targets Notch for degradation, as a direct target of IRF4 in CLL cells and their precursors. Collectively, our studies provide the first in vivo evidence for an essential role of Notch signaling in the development of CLL and establish IRF4 as a critical regulator of Notch signaling during CLL development.

Original languageEnglish (US)
Pages (from-to)41081-41094
Number of pages14
Issue number27
StatePublished - May 25 2016
Externally publishedYes


  • B1 cells
  • CLL
  • IRF4
  • Notch signaling

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this